Indivior Pharmaceuticals, Inc. Stock London S.E.
Stocks
INDV
US45579U1097
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,238.00 GBX | +1.56% |
|
+5.27% | +20.90% |
| Market Cap | 4.95B 4.33B 4B 3.67B 6.95B 477B 7.07B 47.71B 18.74B 233B 18.58B 18.18B 804B | P/E 2026 * |
12.8x | P/E 2027 * | 11.2x |
|---|---|---|---|---|---|
| Enterprise Value | 5B 4.37B 4.04B 3.71B 7.02B 482B 7.15B 48.23B 18.95B 235B 18.79B 18.38B 813B | EV / Sales 2026 * |
3.98x | EV / Sales 2027 * | 3.48x |
| Free-Float |
97.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Indivior Pharmaceuticals, Inc.
| 1 week | +5.27% | ||
| 1 month | +20.78% | ||
| 3 months | +60.36% | ||
| 6 months | +29.91% | ||
| Current year | +20.90% |
| 1 week | 1,160 |  | 1,264 |
| 1 month | 975.5 | | 1,264 |
| 3 years | 554.83 | | 2,020 |
| 5 years | 335 | | 2,020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.56% | +5.27% | +49.52% | -20.18% | 4.99B | |
| +1.08% | -3.84% | +51.50% | +160.13% | 1,031B | |
| +1.19% | -5.10% | +61.09% | +56.36% | 595B | |
| +4.21% | +0.65% | +36.48% | +87.04% | 431B | |
| +0.42% | -0.99% | +30.04% | +22.27% | 326B | |
| +1.03% | -2.10% | +28.32% | +45.08% | 277B | |
| +0.49% | -11.32% | +20.31% | +22.32% | 263B | |
| +1.59% | +3.91% | -22.47% | -36.84% | 224B | |
| +3.70% | +0.98% | +27.03% | +63.38% | 193B | |
| +3.49% | +0.35% | +24.98% | +76.58% | 164B | |
| Average | +2.01% | -3.79% | +30.68% | +47.61% | 389.37B | |
| Weighted average by Cap. | +1.81% | -4.31% | +37.81% | +79.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.26B 1.1B 1.02B 933M 1.77B 121B 1.8B 12.13B 4.76B 59.19B 4.72B 4.62B 204B | 1.31B 1.14B 1.06B 970M 1.84B 126B 1.87B 12.61B 4.95B 61.54B 4.91B 4.8B 212B |
| Net income | 414M 362M 335M 307M 582M 39.94B 592M 4B 1.57B 19.5B 1.56B 1.52B 67.33B | 473M 413M 382M 351M 664M 45.57B 675M 4.56B 1.79B 22.25B 1.78B 1.74B 76.82B |
| Net Debt | 54.5M 47.64M 44.06M 40.43M 76.51M 5.25B 77.84M 525M 206M 2.56B 205M 200M 8.85B | -403M -353M -326M -299M -566M -38.87B -576M -3.89B -1.53B -18.98B -1.51B -1.48B -65.53B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INDV Stock
- INDV Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
